drugset / Trial / NCT00099528
Dose-Finding Study of REN-1654 in Patients With Post-Herpetic Neuralgia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to gain initial safety and efficacy data on the experimental agent REN-1654 in patients with painful post-herpetic neuralgia (PHN).
Timeline
- Start
- 2003-08
- Primary completion
- —
- Completion
- 2004-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | REN-1654 | Unknown | 30 mg | Oral |
| Subject | REN-1654 | Unknown | 100 mg | Oral |